Patient demographics
| Normal controls (n=10) | AS study group (n=78) | AS patients abnormal LVEF (n=14) | p Value (if ⩽ 0.05 by ANOVA) | |
| Age (years) | 63 (5) | 64 (13) | 71 (9) | |
| Male | 2 (20%) | 46 (59%) | 5 (38%) | 0.02 |
| CAD1-150 | 0/0 | 13/36 (36%) | 3/7 (43%) | |
| Hypertension | 0 | 31 (40%) | 2 (14%) | |
| Mean PG (mmHg) | 2 (1) | 37 (18) | 46 (26) | < 0.0001 |
| Peak PG (mmHg) | 3 (1) | 60 (27) | 71 (39) | < 0.0001 |
| EOA (cm2) | 2.3 (0.5) | 0.9 (0.3) | 0.7 (0.2) | < 0.0001 |
| FS (%) | 39 (8) | 39 (7) | 21 (4) | < 0.0001 |
| EF (%) | 77 (9) | 76 (7) | 49 (9) | < 0.0001 |
| LVMI (g/m2) | 69 (29) | 152 (58) | 177 (84) | 0.0002 |
Results are given as mean (SD) unless otherwise indicated.
↵1-150 CAD, coronary artery disease, showing number of patients with CAD/number of patients who underwent coronary angiography
ANOVA, analysis of variance; EF, ejection fraction; EOA, effective orifice area; FS, fractional shortening; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; PG, trans-aortic pressure difference.